Silo Pharma
SILO
12 hedge funds and large institutions have $383K invested in Silo Pharma in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
640% more capital inflows, than outflows
Capital inflows: $390K | Capital outflows: $52.7K
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
33% more funds holding
Funds holding: 9 → 12 (+3)
4.56% more ownership
Funds ownership: 3.24% → 7.8% (+4.6%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$322K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20.4K |
| 4 |
BWM
Bullock Wealth Management
Bloomington,
Indiana
|
+$16.5K |
| 5 |
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$8.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Financial Advocates Investment Management
Olympia,
Washington
|
-$23.9K |
| 2 |
Virtu Financial
New York
|
-$23.1K |
| 3 |
Tower Research Capital (TRC)
New York
|
-$3.69K |
| 4 |
Redwood Wealth Management Group
Medford,
New Jersey
|
-$2K |
SILO Hedge Fund Activity: Q3 2024 in Review
12 of the 6,987 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q3 2024, worth a combined $383K — up 225% from $118K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SILO positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $322K. The largest seller was Financial Advocates Investment Management, exiting entirely with an estimated $23.9K sold.
- 12 institutional investors held Silo Pharma (SILO) as of Q3 2024, up from 9 in Q2 2024.
- Funds reported $383K of Silo Pharma stock for Q3 2024, up 225% quarter-over-quarter.
- 5 funds opened new Silo Pharma positions in Q3 2024 and 2 closed out, a net change of +3 holders.
- The largest Silo Pharma buyer in Q3 2024 was Renaissance Technologies, an estimated $322K added.
- The largest Silo Pharma seller in Q3 2024 was Financial Advocates Investment Management, an estimated $23.9K sold.
Based on aggregated 13F filings for Q3 2024.